Catatonia and the neuroleptics: Psychobiologic significance of remote and recent findings

Comprehensive Psychiatry

Volumn 38, Issue 4, 1997, Pages 193-201

  Blumer, Dietrich ^a,b  

^a UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER   (United States)

^b Epi Care Center   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BENZODIAZEPINE; CARBAMAZEPINE; LEVODOPA; LORAZEPAM; NEUROLEPTIC AGENT;

AFFECTIVE NEUROSIS; ARTICLE; CATATONIA; DISEASE ASSOCIATION; DOPAMINERGIC SYSTEM; DRUG EFFECT; EGO; ELECTROCONVULSIVE THERAPY; EXTRAPYRAMIDAL SYMPTOM; FRONTAL LOBE; HUMAN; PARANOID PSYCHOSIS; PATHOPHYSIOLOGY; RECEPTOR DOWN REGULATION; SCHIZOPHRENIA;

EID: 0030916833     PISSN: 0010440X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0010-440X(97)90027-4     Document Type: Article

References (63)

1. Taylor MA. Catatonia: a review of a behavioral neurologic syndrome. Neuropsychiatry Neuropsychol Behav Neurol 1990; 3:48-72.
2. Lohr JB, Wisniewski AA. Movement Disorders: A Neuropsychiatric Approach. New York, NY: Guilford, 1987.
3. Bush G, Fink M, Petrides G, Dowling F, Francis A, Catatonia. I. Rating scale and standardized examination. Acta Psychiatr Scand 1996;93:129-136.
4. Rosebush PI, Hildebrand AM, Furlong BG, Mazurek MF: Catatonic syndrome in a general psychiatric inpatient population: frequency, clinical presentation, and response to lorazepam. J Clin Psychiatry 1990;51:357-362.
5. Kahlbaum KL. Klinische Abhandlungen über psychische Krankheiten, I. Heft: "Die Katatonie oder das Spannungsirresein." Berlin, Germany: A. Hirschwald, 1874.
6. Kahlbaum KL. Catatonia. Baltimore, MD: The Johns Hopkins University Press, 1973.
7. Kleist K. Schizophrenic symptoms and cerebral pathology. J Ment Sci 1960;106:246-255.
8. Kraepelin E. Dementia praecox and paraphrenia [translation by RM Barclay]. Edinburg, UK: Livingstone, 1919.
9. Lange J. Katatonische Erscheinungen im Rahmen manischer Erkrankungen. Monographie aus dem Gesamtgebiet der Neurologie und Psychiatrie, No. 31. Berlin, Germany: Springer, 1922.
10. Bleuler E. Textbook of Psychiatry [translation by AA Brill]. New York, NY: Macmillan, 1924.
11. Bleuler E. Dementia praecox or the group of schizophrenias [translation by J Zinkin]. New York, NY: International University Press, 1950.
12. Bleuler E. Lehrbuch der Psychiatrie. Achte Auflage von Manfred Bleuler. Berlin, Germany: Springer, 1949.
13. Jung CG. Über die Psychologie der Dementia praecox. Halle a.S., Germany: Karl Marhold, 1907.
14. Jung CG. The Psychology of Dementia Praecox. New York, NY: Nervous and Mental Disease Publishing, 1936.
15. Vogt R. Zur Psychologie der katatonischen Symptome. Zentralbl Nervenheilkunde Psychiatr 1902;19:433-437.
16. Szondi L. Schicksalsanalyse. Basel, Switzerland: Benno Schwabe, 1948.
17. Szondi L. Triebpathologie. Bern, Switzerland: Hans Huber, 1952.
18. Szondi L. Ich-Analye. Bern, Switzerland: Hans Huber, 1956.
19. Szondi L. Lehrbuch der experimentellen Triebdiagnostik. Bern, Switzerland: Hans Huber, 1960.
20. Gadelius B. Human Mentality in the Light of Psychiatric Experience: An Outline of General Psychiatry. London, UK: Oxford, 1933.
21. Rosanoff AJ (ed). Manual of Psychiatry. Ed. 6. New York, NY: Wiley, 1927:106-112.
22. Jones IH. Observations on schizophrenic stereotypies. Compr Psychiatry 1965;6:323-335.
23. Andreasen NC, Olsen S. Negative vs. positive schizophrenia: definition and validation. Arch Gen Psychiatry 1982;39:789-794.
24. Mahendra B. Where have all the catatonics gone? Psychol Med 1981;11:669-671.
25. Carpenter WT, Bartko JJ, Carpenter CL, Strauss JS. Another view of schizophrenia subtypes: a report from the International Pilot Study of Schizophrenia. Arch Gen Psychiatry 1976;33:508-516.
26. Bonner CA, Kent GH. Overlapping symptoms in catatonic excitement and manic excitement. Am J Psychiatry 1936;92:1311-1322.
27. Taylor MA, Abrams R. Catatonia: prevalence and importance in the manic phase of manic-depressive illness. Arch Gen Psychiatry 1977;34:1223-1225.
28. Achté KA. Der Verlauf der Schizophrenien und der schizophreniformen Psychosen. Acta Psychiatr Neurol Scand 1961;155:224-226.
29. Johnson J. Catatonia: the tension insanity. Br J Psychiatry 1993;162:733-738.
30. Caroff SN. The neuroleptic malignant syndrome. J Clin Psychiatry 1980;41:79-83.
31. Stoudemire A, Luther JS. Neuroleptic malignant syndrome and neuroleptic-induced catatonia: differential diagnosis and treatment. Int J Psychiatry Med 1984;14:57-63.
32. Fricchione GI. Neuroleptic catatonia and its relationship to psychogenic death. Biol Psychiatry 1985;20:304-313.
33. Mann SC, Caroff SN, Bleier HR, et al. Lethal catatonia. Am J Psychiatry 1986;143:1374-1381.
34. Price DK, Turnbull GJ, Gregory RP, et al. Lethal catatonia. Am J Psychiatry 1989;155:849-852.
35. White DA, Robins AH. Catatonia: harbinger of the neuroleptic malignant syndrome. Br J Psychiatry 1991;158:419-421.
36. White DA. Catatonia and the neuroleptic malignant syndrome - a single entity? Br J Psychiatry 1992;161:558-560.
37. Gelenberg AJ, Mandel MR. Catatonic reactions to high-potency neuroleptic drugs. Arch Gen Psychiatry 1977;34:947-950.
38. Friedhoff AJ. A strategy for developing novel drugs for the treatment of schizophrenia. Schizophr Bull 1983;9:555-562.
39. Abrams R, Taylor MA. Catatonia: a prospective clinical study. Arch Gen Psychiatry 1976;33:579-581.
40. Gelenberg AJ. The catatonic syndrome. Lancet 1976;2: 1339-1341.
41. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. Ed. 4. Washington, DC: American Psychiatric Association, 1994.
42. Perry JC, Jacobs D. Overview: clinical application of the amytal interview in psychiatric emergency settings. Am J Psychiatry 1982;139:552-559.
43. Rankel HW, Rankel LE. Carbamazepine in the treatment of catatonia. Am J Psychiatry 1988;145:361-362.
44. Neppe VM. Management of catatonic stupor with L-dopa. Clin Neuropharmacol 1988;11:90-91.
45. Donnoli VF. Akinetic catatonia and antidepressants. Acta Psiquiatr Psicol Am Lat 1991;37:325-327.
46. McEvoy JP, Lohr JB. Diazepam for catatonia. Am J Psychiatry 1984;141:284-285.
47. Walter-Ryan WG. Treatment for catatonic symptoms with intramuscular lorazepam. J Clin Psychopharmacol 1985;5: 123-124.
48. Salam SA, Pillai A, Beresford TP. Lorazepam for psychogenic catatonia. Am J Psychiatry 1987;144:1082-1083.
49. Greenfeld D, Conrad C, Kincare P, et al. Treatment of catatonia with low-dose lorazepam. Am J Psychiatry 1987;144: 1224-1225.
50. Salam SA, Kilzieh N. Lorazepam in psychogenic catatonia: an update. J Clin Psychiatry 1988;49(12 Suppl):16-21.
51. Bodkin JA. Emerging uses for high potency benzodiazepines in psychotic disorders. J Clin Psychiatry 1990;51(5 Suppl):41-46.
52. Bush G, Fink M, Petrides G, Dowling F, Francis A. Catatonia. II. Treatment with lorazepam and electroconvulsive therapy. Acta Psychiatr Scand 1996;93:137-143.
53. Philbrick KL, Rummans TA. Malignant catatonia. J Neuropsychiatry Clin Neurosci 1994;6:1-13.
54. Addonizio G, Susman VL, Roth SD. Symptoms of neuroleptic malignant syndrome in 82 consecutive inpatients. Am J Psychiatry 1987;143:1587-1590.
55. Itoh H, Ohtsuka N, Ogita K, et al. Malignant neuroleptic syndrome: its present state in Japan and clinical problems. Folia Psychiatr Neurol Jpn 1977;31:565-576.
56. Keck PE, Pope HG, McElroy SI. Frequency and presentation of neuroleptic malignant syndrome: a prospective study. Am J Psychiatry 1987;144:1344-1346.
57. Fink M. Neuroleptic malignant syndrome and catatonia: one entity or two? Biol Psychiatry 1996;39:1-4.
58. Mazurek ME. Catatonia: relationship to other neuropsychiatric conditions. American Psychiatric Association Symposium, Philadelphia, PA, May 25, 1994.
59. Rosebush PI, Mazurek MF. A consideration of the mechanism by which lorazepam might treat catatonia. J Clin Psychiatry 1991;52:187-188.
60. Gonzalez-Vegas JA. Antagonism of dopamine-mediated inhibition in the nigrostriatal pathway: a mode of action of some catatonia-inducing drugs. Brain Res 1974;80:219-228.
61. Wilcox JA. Perinatal distress and infectious disease as risk factors for catatonia. Psychopathology 1886;19:196-199.
62. Weinberger DR, Aloia MS, Goldberg TE, Berman KF. The frontal lobes and schizophrenia. J Neuropsychiatry Clin Neurosci 1994;6:419-427.
63. Marsden CD, Tarsy D, Baldessarini RJ. Spontaneous and drug-induced movement disorders in psychotic patients. In: Benson DF, Blumer D (eds): Psychiatric Aspects of Neurologic Disease. New York, NY: Grune & Stratton, 1975:219-266.